Related Experiment Videos

[Cardiac natriuretic peptides as markers of left ventricular dysfunction]

T Omland1, A Aakvaag, H Vik-Mo

  • 1Endokrinologisk seksjon, Universitetet i Bergen Haukeland Sykehus.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|March 10, 1997
PubMed
Summary

B-type natriuretic peptide (BNP) is a better screening tool for left ventricular (LV) impairment than atrial natriuretic factor (ANF) or its N-terminal fragment (pro-ANF). However, the diagnostic value of these biomarkers for mild LV dysfunction remains modest.

Related Concept Videos